These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 1937540)

  • 1. T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease.
    Zinkernagel RM; Pircher HP; Ohashi P; Oehen S; Odermatt B; Mak T; Arnheiter H; Bürki K; Hengartner H
    Immunol Rev; 1991 Aug; 122():133-71. PubMed ID: 1937540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
    Hengartner H
    Verh Dtsch Ges Pathol; 1994; 78():177-9. PubMed ID: 7533982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology.
    Ehl S; Hombach J; Aichele P; Rülicke T; Odermatt B; Hengartner H; Zinkernagel R; Pircher H
    J Exp Med; 1998 Mar; 187(5):763-74. PubMed ID: 9480986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
    Ohashi PS; Oehen S; Aichele P; Pircher H; Odermatt B; Herrera P; Higuchi Y; Buerki K; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5185-94. PubMed ID: 8496610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
    Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
    J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells causing immunological disease.
    Zinkernagel RM; Pircher H; Ohashi PS; Hengartner H
    Springer Semin Immunopathol; 1992; 14(2):105-13. PubMed ID: 1475738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
    Speiser DE; Miranda R; Zakarian A; Bachmann MF; McKall-Faienza K; Odermatt B; Hanahan D; Zinkernagel RM; Ohashi PS
    J Exp Med; 1997 Aug; 186(5):645-53. PubMed ID: 9271580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.
    Ohashi PS; Oehen S; Buerki K; Pircher H; Ohashi CT; Odermatt B; Malissen B; Zinkernagel RM; Hengartner H
    Cell; 1991 Apr; 65(2):305-17. PubMed ID: 1901764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of autoimmunity in the context of T-cell tolerance: insights from natural and transgenic animal model systems.
    Siegel RM; Katsumata M; Komori S; Wadsworth S; Gill-Morse L; Jerrold-Jones S; Bhandoola A; Greene MI; Yui K
    Immunol Rev; 1990 Dec; 118():165-92. PubMed ID: 2150401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.
    Woopen C; Straub T; Schweier O; Aichele U; Düker K; Boehm T; Pircher H
    Eur J Immunol; 2018 Jan; 48(1):120-127. PubMed ID: 28921501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
    Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
    J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
    Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
    Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
    Pircher H; Bürki K; Lang R; Hengartner H; Zinkernagel RM
    Nature; 1989 Nov; 342(6249):559-61. PubMed ID: 2573841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen.
    Hämmerling GJ; Schönrich G; Momburg F; Auphan N; Malissen M; Malissen B; Schmitt-Verhulst AM; Arnold B
    Immunol Rev; 1991 Aug; 122():47-67. PubMed ID: 1834543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.